advertisement
Eye 119
Showing records 1 to 25 | Display all abstracts in Eye109577 External validation of a deep learning detection system for glaucomatous optic neuropathy: a real-world multicentre study
Qian X
Eye 2023; 37: 3813-3818
109631 PACS plus criteria: a retrospective cohort review of 612 consecutive patients treated with bilateral YAG peripheral iridotomies
Young SL
Eye 2023; 37: 3834-3838
109252 Measures of multiple deprivation and visual field loss in glaucoma clinics in England: lessons from big data
Rathore M
Eye 2023; 37: 3615-3620
109666 Phenotypic expressions of the optic disc in primary open-angle glaucoma
Grassi L
Eye 2023; 37: 3839-3846
109398 Changing from preserved, to preservative-free cyclosporine 0.1% enhanced triple glaucoma therapy: impact on ocular surface disease-a randomized controlled trial
Konstas AG
Eye 2023; 37: 3666-3674
108844 Silicone oil residual after vitrectomy for rhegmatogenous retinal detachment
Zhao H
Eye 2023; 37: 1829-1833
109605 Estimating the rate of severe visual loss (wipe-out) following cataract surgery, a British Ophthalmological Surveillance Unit (BOSU) study
Ramsden C
Eye 2023; 37: 3787-3792
110010 Optical coherence tomographic findings of glaucomatous eyes with papillomacular retinoschisis
Ishida T
Eye 2024; 38: 266-273
109608 Dense optic nerve head deformation estimated using CNN as a structural biomarker of glaucoma progression
Salehi A
Eye 2023; 37: 3819-3826
110009 Do African American patients with glaucoma ask their eye providers the questions they have?
Beznos B
Eye 2024; 38: 279-283
109730 Improving glaucoma staging in clinical practice by combining the ICD-10 glaucoma severity classification system and optical coherence tomography
Leshno A
Eye 2024; 38: 153-160
108887 Comparing combined laser iridoplasty and surgical iridectomy with trabeculectomy in treatment of refractory acute primary angle closure without significant cataract: a randomized controlled trial
Nguyen HX
Eye 2023; 37: 2139-2144
109775 Effectiveness and safety of XEN45 implant over 12 months of follow-up: data from the XEN-Glaucoma Treatment Registry
Oddone F
Eye 2024; 38: 103-111
109260 The Royal College of Ophthalmologists' National Ophthalmology Database Study of Cataract Surgery: Report 12, Risk factors for suprachoroidal haemorrhage during cataract surgery
Stewart S
Eye 2023; 37: 1778-1787
110010 Optical coherence tomographic findings of glaucomatous eyes with papillomacular retinoschisis
Kita Y
Eye 2024; 38: 266-273
108844 Silicone oil residual after vitrectomy for rhegmatogenous retinal detachment
Cheng T
Eye 2023; 37: 1829-1833
109730 Improving glaucoma staging in clinical practice by combining the ICD-10 glaucoma severity classification system and optical coherence tomography
Tsamis E
Eye 2024; 38: 153-160
109252 Measures of multiple deprivation and visual field loss in glaucoma clinics in England: lessons from big data
Shweikh Y
Eye 2023; 37: 3615-3620
109605 Estimating the rate of severe visual loss (wipe-out) following cataract surgery, a British Ophthalmological Surveillance Unit (BOSU) study
Shweikh Y
Eye 2023; 37: 3787-3792
110009 Do African American patients with glaucoma ask their eye providers the questions they have?
Sayner R
Eye 2024; 38: 279-283
109631 PACS plus criteria: a retrospective cohort review of 612 consecutive patients treated with bilateral YAG peripheral iridotomies
Cheng KKW
Eye 2023; 37: 3834-3838
109577 External validation of a deep learning detection system for glaucomatous optic neuropathy: a real-world multicentre study
Xian S
Eye 2023; 37: 3813-3818
108887 Comparing combined laser iridoplasty and surgical iridectomy with trabeculectomy in treatment of refractory acute primary angle closure without significant cataract: a randomized controlled trial
Nguyen ND
Eye 2023; 37: 2139-2144
109730 Improving glaucoma staging in clinical practice by combining the ICD-10 glaucoma severity classification system and optical coherence tomography
Tsamis E
Eye 2024; 38: 153-160
109775 Effectiveness and safety of XEN45 implant over 12 months of follow-up: data from the XEN-Glaucoma Treatment Registry
Roberti G
Eye 2024; 38: 103-111